The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Open accessAbstract
Nigrostriatal dopaminergic neurons express many nicotinic acetylcholine receptor (nAChR) subunits capable of forming multiple nAChR subtypes. These subtypes are expressed differentially along the neuron and presumably mediate diverse responses. β3 subunit mRNA has restricted expression but is abundant in the substantia nigra and ventral tegmental areas. To investigate the potential role(s) of nicotinic receptors containing the β3 subunit in dopaminergic tracts, we generated mice with a null mutation in the β3 gene. We were thereby able to identify a population of β3-dependent α-conotoxin MII-binding nAChRs that modulate striatal dopamine release. Changes were also observed in locomotor activity and prepulse inhibition of acoustic startle, behaviors that are controlled, in part, by nigrostriatal and mesolimbic dopaminergic activity, respectively, suggesting that β3-containing nAChRs modulate these behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As β3 mRNA is detected in the substantia nigra, VTA, and medial habenula (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
The cited source says what the claim attributes to it.
In the citing paper
“behaviors that are controlled, at least in part, by nigrostriatal and mesolimbic dopaminergic activity (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
The cited source says what the claim attributes to it.
In the citing paper
“Changes were also reported for locomotor activity and prepulse inhibition of acoustic startle”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Visualizing an Olfactory Sensory Map
Mombaerts, P., Wang, F., Dulac, C. G., Chao, S. K., Nemes, A., Mendelsohn, M. M., Edmondson, J., & Axel, R. (1996) · Cell · doi:10.1016/s0092-8674(00)81387-2 · Cited by 1,992
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051622798 · Cited by 673
Self-citationAbnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
The new mouse genetics: Altering the genome by gene targeting
Capecchi, M. R. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90029-2 · Cited by 611
Cited by
Sorted by citations
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401
Self-citationDiversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 330
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Nicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Self-citationExley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 271
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242
Self-citationGrady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Self-citationPicciotto, M. R. (2007) · Frontiers in bioscience · doi:10.2741/2695 · Cited by 212
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197
Self-citationα6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Analogs of α-Conotoxin MII Are Selective for α6-Containing Nicotinic Acetylcholine Receptors
McIntosh, J. M., Azam, L., Staheli, S. T., Dowell, C. D., Lindstrom, J. M., Kuryatov, A., Garrett, J. E., Marks, M. J., & Whiteaker, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.944 · Cited by 194
Self-citationAlpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors
Azam, L., & McIntosh, J. M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.47 · Cited by 179
Self-citationBorn to lead? A twin design and genetic association study of leadership role occupancy
Jan-emmanuel De Neve, A., Mikhaylov, S., Dawes, C. T., Christakis, N. A., & Fowler, J. H. (2012) · The Leadership Quarterly · doi:10.1016/j.leaqua.2012.08.001 · Cited by 184
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 191
Nicotine Gateway Effects on Adolescent Substance Use
Ren, M., & Lotfipour, S. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2019.7.41661 · Cited by 166
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 165
The role of the habenula in drug addiction
Velasquez, K. M., Molfese, D. L., & Salas, R. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00174 · Cited by 155
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154
Exposure to nicotine and sensitization of nicotine-induced behaviors
Vezina, P., McGehee, D. S., & Green, W. N. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.038 · Cited by 153
Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 151
Self-citationIdentification of embryonic stem cell–derived midbrain dopaminergic neurons for engraftment
Ganat, Y. M., Calder, E. L., Kriks, S., Nelander, J., Tu, E. Y., Jia, F., Battista, D., Harrison, N. L., Parmar, M., Tomishima, M. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58767 · Cited by 141
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 139
The medial habenula: still neglected
Viswanath, H., Carter, A. Q., Baldwin, P. R., Molfese, D. L., & Salas, R. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00931 · Cited by 142
Gotti, C., Moretti, M., Clementi, F., Riganti, L., McIntosh, J. M., Collins, A. C., Marks, M. J., & Whiteaker, P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011940 · Cited by 133
Self-citationFowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 135
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 129
Self-citationGotti, C., Moretti, M., Bohr, I., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I., Perry, R., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 137
Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-10.2010 · Cited by 127
Self-citationNicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 116
Nicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 116
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112
Self-citationNicke, A., Wonnacott, S., & Lewis, R. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04145.x · Cited by 109
Graef, S., Schönknecht, P., Sabri, O., & Hegerl, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2153-8 · Cited by 107
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106
Self-citationWehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 105
Self-citationStriatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum
Exley, R. A., McIntosh, J. M., Marks, M. J., Maskos, U., & Cragg, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-11.2012 · Cited by 107
Self-citationChernyavsky, A. I., Arredondo, J., Marubio, L. M., & Grando, S. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01492 · Cited by 102
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100
Larsson, A. C., Jerlhag, E., Svensson, L., Söderpalm, B., & Engel, J. A. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.10.002 · Cited by 98
Hoft, N. R., Corley, R. P., McQueen, M. B., Schlaepfer, I. R., Huizinga, D. H., & Ehringer, M. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.122 · Cited by 97
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97
Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95
Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95
“Together with previous data (Le Novere et al, 1996; le Novere et al, 1999; Klink et al, 2001; Cui et al , 2003; Drenan et al, 2008; Dwoskin et al, 2008), the current findings suggest that α 6 β 2*nAChRs in areas other than the NAc shell regulate nicotine locomotor activation.”
Self-citationQuik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
Self-citationKuzmin, A. V., Jerlhag, E., Liljequist, S., & Engel, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1375-5 · Cited by 89
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89
Moretti, M., Vailati, S., Zoli, M., Lippi, G., Riganti, L., Longhi, R., Viegi, A., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.85 · Cited by 89
Cholinergic left-right asymmetry in the habenulo-interpeduncular pathway
Hong, E., Santhakumar, K., Akitake, C. A., Ahn, S. J., Thisse, C., Thisse, B., Wyart, C., Mangin, J., & Halpern, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319566110 · Cited by 90
Evidence of Missense Mutations on the Neuregulin 1 Gene Affecting Function of Prepulse Inhibition
Hong, L. E., Wonodi, I., Stine, O. C., Mitchell, B. D., & Thaker, G. K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.011 · Cited by 84
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Xiu, J., Nordberg, A. K., Zhang, J., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.023 · Cited by 82
Jerlhag, E., Egecioglu, E., Dickson, S. L., Svensson, L., & Engel, J. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.02.006 · Cited by 78
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms
Dutertre, S., Nicke, A., & Tsetlin, V. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.011 · Cited by 77
Azam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77
Self-citationJerlhag, E., Grøtli, M., Luthman, K., Svensson, L., & Engel, J. A. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl049 · Cited by 78
An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants
Baddick, C. G., & Marks, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.019 · Cited by 75
Self-citationGreenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 73
McClure‐Begley, T. D., King, N. M., Collins, A. C., Stitzel, J. A., Wehner, J. M., & Butt, C. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052274 · Cited by 72
Self-citationPortugal, G. S., & Gould, T. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.006 · Cited by 73
Gotti, C., Moretti, M., Zanardi, A., Gaimarri, A., Champtiaux, N., Changeux, J., Whiteaker, P., Marks, M., Clementi, F., & Zoli, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015925 · Cited by 72
Self-citationKing, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70
Tsetlin, V. I., Utkin, Y. N., & Kasheverov, I. E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.032 · Cited by 69
The Role of the Habenula in Nicotine Addiction
Baldwin, P. R., Alanis, R., & Salas, R. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-002 · Cited by 67
Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63
Self-citationZhang, J., & Berg, D. K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.124578 · Cited by 61
Broadbent, S. D., Groot‐Kormelink, P. J., Krashia, P., Harkness, P. C., Millar, N. S., Beato, M., & Sivilotti, L. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026682 · Cited by 60
Meyer, E. L., Yoshikami, D., & McIntosh, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05266.x · Cited by 58
Self-citationAzam, L., & McIntosh, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024513 · Cited by 56
Self-citationKeller, J. J., Keller, A. B., Bowers, B. J., & Wehner, J. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.004 · Cited by 57
Giribaldi, J., & Dutertre, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.063 · Cited by 57
Whiteaker, P., Cooper, J. F., Salminen, O., Marks, M. J., McClure‐Begley, T. D., Brown, R. W. B., Collins, A. C., & Lindstrom, J. M. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21181 · Cited by 56
Self-citationNicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 57
Interplay between Smoking-induced Genotoxicity and Altered Signaling in Pancreatic Carcinogenesis
Momi, N., Kaur, S., Ponnusamy, M. P., Kumar, S., Wittel, U. A., & Batra, S. K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs186 · Cited by 54
Khwaja, M., McCormack, A., McIntosh, J. M., Di Monte, D. A., & Quik, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04177.x · Cited by 54
Self-citationNicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 52
Self-citationEndo, T., Yanagawa, Y., Obata, K., & Isa, T. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00211.2005 · Cited by 61
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 55
Engle, S. E., Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087346 · Cited by 54
Self-citationNicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Marritt, A. M., Cox, B. C., Yasuda, R. P., McIntosh, J. M., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012369 · Cited by 50
Self-citationDecreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49
Self-citationNicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior
Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 50
Self-citationRezvani, K., Teng, Y., Pan, Y., Dani, J. A., Lindstrom, J., García Gras, E. A., McIntosh, J. M., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4723-08.2009 · Cited by 46
Self-citationBorroni, V., & Barrantes, F. J. (2021) · Membranes · doi:10.3390/membranes11090664 · Cited by 49
Structure of neuronal nicotinic receptors.
Fasoli, F., & Gotti, C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_1 · Cited by 41
The Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 47
Metadata
- Authors
- Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., Stitzel, J. A., McIntosh, J. M., Boulter, J., Collins, A. C., & Heinemann, S. F.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-12-03
- Volume
- 23
- Issue
- 35
- Pages
- 11045-11053
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6741047
- OpenAlex
- W2130326884
- Cited by
- 213
- References
- 53
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 17 · 2013: 9 · 2012: 12
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k05da000197-07, 5p01da010156-05, MH53631)
- National Institute on Aging (2T32AG00216, T32AG000216)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA00197, DA-14369, R01DA014369, R01DA012242, DA10156, DA12242)
- National Institute of Neurological Disorders and Stroke (NS10830, F32NS010830)
- National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, beta3 subunit, alpha-conotoxin MII, dopamine release, nigrostriatal pathway, substantia nigra, ventral tegmental area, null mice, locomotor activity, prepulse inhibition, acoustic startle response, mesolimbic dopamine system, striatum
- MeSH terms
- Animals, Behavior, Animal, Binding, Competitive, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Female, Ligands, Male, Mice, Mutant Strains, Motor Activity, Neural Inhibition, Nicotine, Receptors, Nicotinic, RNA, Messenger, Reflex, Startle, Substantia Nigra, Synaptosomes, In Situ Hybridization, Mice, Knockout, Gene Targeting, Conotoxins, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
